Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury

Basic Research in Cardiology

Volumn 105, Issue 2, 2010, Pages 169-179

  Szelid, Zsolt ^a,b,c   Pokreisz, Peter ^a,b   Liu, Xiaoshun ^a,b   Vermeersch, Pieter ^a   Marsboom, Glenn ^a   Gillijns, Hilde ^a   Pellens, Marijke ^a   Verbeken, Erik ^b   Van De Werf, Frans ^b   Collen, Desire ^a   Janssens, Stefan P ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cardiac ischemia reperfusion; Nitric oxide; Nitric oxide synthase 3; Retrograde gene transfer

Indexed keywords

ADENOVIRUS VECTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MYELOPEROXIDASE; NOS3 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOAVAILABILITY; CARDIOSELECTIVITY; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DIASTOLE; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION; GENE TRANSFER; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOREACTIVITY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REPERFUSION INJURY; SYSTOLE; ANIMAL; GENE THERAPY; GENETICS; HEART INFARCTION; HEART MUSCLE; HEMODYNAMICS; LEUKOCYTE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SWINE; TRANSGENE; VALIDATION STUDY;

ANIMALS; APOPTOSIS; ENDOTHELIAL CELLS; GENE THERAPY; HEMODYNAMICS; LEUKOCYTES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; RANDOM ALLOCATION; SWINE; TRANSGENES;

EID: 77950354449     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-009-0077-4     Document Type: Article

References (45)

1. Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C, Steinbeck G, Baretton G, Middeler G, Katus H, Franz WM (2000) Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 7: 232-240
2. Bott-Flugel L, Weig HJ, Knodler M, Stadele C, Moretti A, Laugwitz KL, Seyfarth M (2005) Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function. J Mol Med 83: 526-534
3. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B (2003) Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res 57: 55-62
4. Chao J, Yin H, Yao YY, Shen B, Smith RS Jr, Chao L (2006) Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation. Hum Gene Ther 17: 1201-1213
5. De Frutos T, Sanchez de Miguel L, Farre J, Gomez J, Romero J, Marcos-Alberca P, Nunez A, Rico L, Lopez-Farre A (2001) Expression of an endothelial-type nitric oxide synthase isoform in human neutrophils: modification by tumor necrosis factor-alpha and during acute myocardial infarction. J Am Coll Cardiol 37: 800-807
6. Elrod JW, Calvert JW, Gundewar S, Bryan NS, Lefer DJ (2008) Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc Natl Acad Sci USA 105: 11430-11435
7. Elrod JW, Greer JJ, Bryan NS, Langsten W, Szot JF, Gebregzlabher H, Janssens S, Feelisch M, Lefer DJ (2006) Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler Thromb Vase Biol 26: 1517-1523
8. Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, Ruetten H, Ertl G, Bauersachs J (2008) Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation 118: 818-827
9. Frantz S, Adamek A, Fraccarollo D, Tillmanns J, Widder JD, Dienesch C, Schafer A, Podolskaya A, Held M, Ruetten H, Ertl G, Bauersachs J (2009) The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol 104: 773-779
10. Garcia-Dorado D, Agullo L, Sartorio CL, Ruiz-Meana M (2009) Myocardial protection against reperfusion injury: the cGMP pathway. Thromb Haemost 101: 635-642
11. Hall G, Hasday JD, Rogers TB (2006) Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 41: 580-591
12. Hamid SA, Totzeck M, Drexhage C, Thompson I, Fowkes RC, Rassaf T, Baxter GF (2009) Nitric oxide/cGMP signalling mediates the cardioprotective action of adrenomedullin in reperfused myocardium. Basic Res Cardiol. doi:10.1007/s00395- 009-0058-7
13. Heinzel FR, Gres P, Boengler K, Duschin A, Konietzka I, Rassaf T, Snedovskaya J, Meyer S, Skyschally A, KeIm M, Heusch G, Schulz R (2008) Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res 103: 1120-1127
14. Heusch G, Boengler K, Schulz R (2008) Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation 118: 1915-1919
15. HeuschG,PostH,MichelMC,KelmM,SchulzR(2000) Endogenousnitricoxideandmyocardialadaptation-ischemia.CircRes87: 146-152(Pubitemid30616911)
16. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD (2004) Cardiomyocyte-speeific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94: 1256-1262
17. Janssens SP, Bloch KD, Nong Z, Gerard RD, Zoldhelyi P, Collen D (1996) Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 98: 317-324
18. Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, Borow K, Dittrich H, Zsebo KM, Hajjar RJ (2009) Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail 15: 171-181
19. Jones SP, Girod WG, Palazzo AJ, Granger DN, Grisham MB, Jourd'Heuil D, Huang PL, Lefer DJ (1999) Myocardial ischemiareperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol 276: H1567-H1573
20. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ (2004) Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 286: H276-H282
21. Kupatt C, Dessy C, Hinkel R, Raake P, Daneau G, Bouzin C, Boekstegers P, Feron O (2004) Heat shock protein 90 transfection reduces ischemia-reperfusion- induced myocardial dysfunction via reciprocal endothelial NO synthase serine 1177 phosphorylation and threonine 495 dephosphorylation. Arterioscler Thromb Vase Biol 24: 1435-1441
22. Kupatt C, Hinkel R, Vachenauer R, Horstkotte J, Raake P, Sandner T, Kreuzpointner R, Muller F, Dimmeler S, Feron O, Boekstegers P (2003) VEGF165 transfection decreases postischemic NF-kappa B-dependent myocardial reperfusion injury in vivo: role of eNOS phosphorylation. FASEB J 17: 705-707
23. Kupatt C, Hinkel R, von Bruhl ML, Pohl T, Horstkotte J, Raake P, El Aouni C, Thein E, Dimmeler S, Feron O, Boekstegers P (2007) Endothelial nitric oxide synthase overexpression provides a functionally relevant angiogenic switch in hibernating pig myocardium. J Am Coll Cardiol 49: 1575-1584
24. Lefer AM, Campbell B, Scalia R, Lefer DJ (1998) Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation 98: 1322-1328
25. Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S (2007) Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am. Coll Cardiol 50: 808-817
26. MacArthur PH, Shiva S, Gladwin MT (2007) Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J Chromatogr B Analyt Technol Biomed Life Sci 851: 93-105
27. Maejima Y, Adachi S, Morikawa K, Ito H, Isobe M (2005) Nitric oxide inhibits myocardial apoptosis by preventing caspase-3 activity via S-nitrosylation. J Mol Cell Cardiol 38: 163-174
28. Mahon NG, Madden BP, Caforio AL, Elliott PM, Haven AJ, Keogh BE, Davies MJ, McKenna WJ (2002) Immunohistologic evidence of myocardial disease in apparently healthy relatives of patients with dilated cardiomyopathy. J Am Coll Cardiol 39: 455-462
29. Matsubara H, Takaki M, Yasuhara S, Araki J, Suga H (1995) Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better alternative to exponential time constant. Circulation 92: 2318-2326
30. Matsui T, Tao J, del Monte F, Lee KH, Li L, Picard M, Force TL, Franke TF, Hajjar RJ, Rosenzweig A (2001) Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 104: 330-335
31. Miura T, Miki T (2008) Limitation of myocardial infarct size in the clinical setting: current status and challenges in translating animal experiments into clinical therapy. Basic Res Cardiol 103: 501-513
32. Moens AL, Champion HC, Claeys MJ, Tavazzi B, Kaminski PM, Wolin MS, Borgonjon DJ, Van Nassauw L, Haile A, Zviman M, Bedja D, Wuyts FL, Elsaesser RS, Cos P, Gabrielson KL, Lazzarino G, Paolocci N, Timmermans JP, Vrints CJ, Kass DA (2008) High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation 117: 1810-1819
33. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14: 157-167
34. Padilla F, Garcia-Dorado D, Agullo L, Inserte J, Paniagua A, Mirabet S, Barrabes JA, Ruiz-Meana M, Soler-Soler J (2000) L-Arginine administration prevents reperfusion-induced cardiomyocyte hypercontracture and reduces infarct size in the pig. Cardiovasc Res 46: 412-420
35. Palazzo AJ, Jones SP, Anderson DC, Granger DN, Lefer DJ (1998) Coronary endothelial P-selectin in pathogenesis of myocardial ischemia- reperfusion injury. Am J Physiol 275: H1865-H1872
36. Raake PW, Hinkel R, Muller S, Delker S, Kreuzpointner R, Kupatt C, Katus HA, Kleinschmidt JA, Boekstegers P, Muller OJ (2008) Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adenoassociated viral (AAV) vectors. Gene Ther 15: 12-17
37. Rajagopalan S, Olin J, Deitcher S, Pieczek A, Laird J, Grossman PM, Goldman CK, McEllin K, Kelly R, Chronos N (2007) Use of a constitutively active hypoxia-inducible factor-!alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience. Circulation 115: 1234-1243
38. Schulz R, Keim M, Heusch G (2004) Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 402-413
39. Shiva S, Gladwin MT (2009) Nitrite mediates cytoprotection after ischemia/reperfusion by modulating mitochondrial function. Basic Res Cardiol 104: 113-119
40. Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL, Charbonneau F, Cohen E, Curtis M, Buller CE, Mendelsohn FO, Dib N, Page P, Ducas J, Plante S, Sullivan J, Macko J, Rasmussen C, Kessler PD, Rasmussen HS (2006) Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther 13: 1503-1511
41. Szelid Z, Sinnaeve P, Vermeersch P, Gillijns H, Pellens M, Laurysens V, Van Pelt N, Flameng W, Sergeant P, Herijgers P, Pokreisz P, Van Zonneveld AJ, Verbeken E, Collen D, Janssens S (2002) Preexisting antiadenoviral immunity and regional myocardial gene transfer: modulation by nitric oxide. Hum Gene Ther 13: 2185-2195
42. Takahashi SS, Omori Y, Miyazaki H, Yoshino F, Shoji H, Lee MC, Todoki K, Kamibayashi M, Murakami E (2003) Real-time monitoring of nitric oxide in ischemic myocardium using an NOselective electrode calibrated by electron spin resonance. Life Sci 74: 75-85
43. Verma S, Maitland A, Weisel. RD, Fedak PW, Pomroy NC, Li SH, Mickle DA, Li RK, Rao V (2002) Novel cardioprotective effects of tetrahydrobiopterin after anoxia and reoxygenation: Identifying cellular targets for pharmacologic manipulation. J Thorac Cardiovasc Surg 123: 1074-1083
44. Westermann D, Riad A, Richter U, Jager S, Savvatis K, Schuchardt M, Bergmann N, Tolle M, Nagorsen D, Gotthardt M, Schultheiss HP, Tschope C (2009) Enhancement of the endothelial NO synthase attenuates experimental diastolic heart failure. Basic Res Cardiol 104: 499-509
45. Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357: 1121-1135